Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) for the period ending June 30, 2017. The filing reports the entry into a material definitive agreement regarding a public equity offering and the closing of that transaction.
Key Financial Metrics
- Equity Raised: The Company sold 3,500,000 shares of common stock at a public offering price of $9.00 per share.
- Gross Proceeds: Approximately $31.5 million received upon closing on June 30, 2017.
- Debt Reduction: The Company intends to use net proceeds to repay $25.0 million of outstanding indebtedness under its revolving credit facility.
- Existing Debt: As of March 31, 2017, borrowings under the revolving credit facility totaled $128.9 million with a weighted average interest rate of approximately 2.92%.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to 525,000 additional shares.
Material Changes
The primary material change is the increase in equity capital and the corresponding reduction in debt. The filing does not provide comparative financial metrics (revenue, profit, or cash flow) for the current period versus the prior period, as this is a transaction-specific report rather than a periodic financial statement.
Outlook, Management Commentary, and Risks
- Use of Proceeds: Net proceeds will be contributed to the Operating Partnership to repay debt and fund future acquisitions or general corporate purposes.
- Capital Program: The Company intends to re-borrow amounts repaid under the revolving credit facility to fund its capital program.
- Credit Facility Terms: The initial termination date of the revolving credit facility is December 2, 2019, with a potential one-year extension if no event of default occurs.
- Legal Opinion: Venable LLP provided an opinion regarding the legality of the shares issued.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm the exact amount of debt repaid from the revolving credit facility post-closing.
- Check if the underwriters exercised the 30-day option to purchase the additional 525,000 shares.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification and termination provisions.
- Monitor future borrowings under the revolving credit facility to assess leverage levels.